SlideShare ist ein Scribd-Unternehmen logo
1 von 14
高齢者の掻痒感
JAMA 2013;310(22):2443-2450
高齢者における掻痒感

•

高齢者では3つの機序で掻痒感を来す
•

皮膚バリア機能の低下
Immunosenescence(加齢に伴う免疫機能低下)
神経症(Neuropathy)

•

これらの機序を理解することが治療に繋がる.
•

皮膚バリア機能の低下
•

皮膚の保水性は皮膚表面の脂質複合体が関与している.
Care of the Aging Patient: From Evidence to Action Clinical Review & Education

Pruritus in the Older Patient

この複合体層は非常に薄く, テープを10-20回剥がすと全て無くなる位
Figure. The Epidermal Water Barrier

Epidermal water barrier

高齢者ではこの層の修復速度,

Lipid lamellae
S T R AT U M C O R N E U M ( S C )

機能自体が低下.

3 Lipid processing

Corneocytes

SG-SC interface

Corneocyte

感想皮膚は≥65yの50%以上で

Lamellar body
contents

認められる所見.

S T R AT U M G R A N U L O S U M ( S G )

Granular cells

2 Lipid secretion
Lamellar body
(containing lipids
and enzymes)

S T R AT U M S P I N O S U M

Spinous cells

1 Lipid synthesis
Granular cell

S T R AT U M B A S A L E

Basal cells

Spinous cell
DERMIS

The keratinocytes of the granular cell
layer make and secrete lipid into the
spaces between corneocytes, the
anucleate keratinocytes of the
stratum corneum. This lipid is
processed by enzymes into lipid
bilayers that are an effective water
barrier. Individuals of advanced age
(>80 years) have reduced lipid
synthesis and secretion. Moderately
aged individuals (50-80 years) make
and secrete lipid normally but have a
defect in lipid processing. Patients of
advanced age and, to a lesser extent,
moderate age both form a less
effective water barrier and repair a
damaged barrier (caused by irritants
such as detergents and soaps) less
effectively.
•

Immunosenescence(加齢に伴う免疫低下)
•

•

皮膚の前炎症状態であり, 湿疹や他の皮膚炎症反応に関与する

神経症(Neuropathy)
•

Sensory neuropathy (主に糖尿病によるもの)で全身性の掻痒感,
Neural impingementで局所的∼全身の掻痒感を来す.
掻痒感への対応

Clinical Review & Education Care of the Aging Patient: From Evidence to Actio

•

先ずチェックするポイント
Box 1. Evaluation and Management of Elderly Patients
With Pruritus

•

掻痒についての病歴, 部位

•

薬剤の評価(外用, 内服)

•

疥癬, 皮膚乾燥のチェック

•

Lab; 肝不全, 腎不全, 電解質
 甲状腺機能異常のチェック.

1. Take directed history detailing severity (on a 0-10 scale), location
(localized vs generalized), and modifying factors for the patient’s
itch (bathing).
2. Review medications (topical and systemic).
3. Perform physical examination for evidence of scabies (burrows,
genital lesions) and dry skin (fissured, red patches on legs, flanks,
and arms).
4. Order basic laboratory evaluation (complete blood cell count, fasting plasma glucose, thyrotropin, liver function tests, serum urea
nitrogen/creatinine, calcium, phosphorus).
5. Treat for xerosis.
6. Treat for scabies if found.
7. If rash is present, initiate topical therapy, obtain potassium hydroxide preparation, order skin biopsy, or refer to a dermatologist if initial therapy does not improve the rash.
8. If no rash is present, initiate metabolic workup (thyroid, parathyroid, iron deficiency) and evaluate for malignancy or for
neuropathy. If no rash is present and skin changes are due to
scratching, assess for scabies, obtain a potassium hydroxide
preparation, consider skin biopsy, pursue a metabolic workup,
and evaluate for malignancy or neuropathy.
•
•

乾燥皮膚, 疥癬があれば対応
皮疹があれば,

*水酸化カリウム外用; カリ石ケン®

Clinical Review & Education Care of the Aging Patient: From Evidence to Actio

•

まず水酸化カリウム外用を使用
改善なければ皮膚生検 or皮膚科へ.

•

皮疹がなければ,
•

代謝内分泌のチェック
(甲状腺, 副甲状腺, 鉄欠乏)
悪性腫瘍, 神経症のチェック

•

水酸化K外用を使用し,
改善なければ生検 or 皮膚科へ

Box 1. Evaluation and Management of Elderly Patients
With Pruritus
1. Take directed history detailing severity (on a 0-10 scale), location
(localized vs generalized), and modifying factors for the patient’s
itch (bathing).
2. Review medications (topical and systemic).
3. Perform physical examination for evidence of scabies (burrows,
genital lesions) and dry skin (fissured, red patches on legs, flanks,
and arms).
4. Order basic laboratory evaluation (complete blood cell count, fasting plasma glucose, thyrotropin, liver function tests, serum urea
nitrogen/creatinine, calcium, phosphorus).
5. Treat for xerosis.
6. Treat for scabies if found.
7. If rash is present, initiate topical therapy, obtain potassium hydroxide preparation, order skin biopsy, or refer to a dermatologist if initial therapy does not improve the rash.
8. If no rash is present, initiate metabolic workup (thyroid, parathyroid, iron deficiency) and evaluate for malignancy or for
neuropathy. If no rash is present and skin changes are due to
scratching, assess for scabies, obtain a potassium hydroxide
preparation, consider skin biopsy, pursue a metabolic workup,
and evaluate for malignancy or neuropathy.
•

病歴での注意点;
•

掻痒感の程度はVASを使用する.
6-8pt以上ならば睡眠を障害するくらいの掻痒感と捉え, 積極的に介入.

•

強い掻痒感では疥癬を必ずチェック. 特に突如発症で施設入所歴が
ある場合, 頭皮がスペアされる場合はさらに疑う

•

入浴との関連も重要な情報.
入浴にて軽快する場合は乾燥皮膚を示唆する病歴.
入浴後分∼時間単位で再出現し, 入浴で改善すればさらに有用.

•

乾燥皮膚では湿度の低い冬場で特に増悪し,
四肢, 体幹の掻痒感が多く, 湿っている腋窩, 鼠径, 顔面, 頭皮では
少ないこともポイント.
•

薬剤歴; 外用もチェック.
•

外用薬の使用方法とそれによる症状の変化にも突っ込む.
外用による接触性皮膚炎の可能性もあり.

•

内服薬による掻痒感も知られていないが多い原因
•

薬剤による一過性の発疹と掻痒感(皮疹が無い場合もあり)
 ACEI, サリチル酸, クロロキン, Ca-ch阻害薬で報告あり.

•

薬剤による胆汁うっ滞

•

薬剤による皮疹と掻痒感

•

薬剤開始後数週で掻痒感が生じているならば中断すべき.
•

掻痒感, じんま疹(+)の高齢者と
年齢をMatchさせたControl群を比較すると,
•

前者ではCa-ch阻害薬の使用率が2-4倍であり,
Thiazide使用率が2倍であった.

•

この結果よりCCBを中断してみると, 3.4ヶ月で83%が改善.
再投与した9例中8例で平均4dでじんま疹が出現した.

•

CCB内服開始後数年経ってから生じる例もあり,
掻痒感やじんま疹でCCB内服している患者では中止するのも良い手
•

薬剤とUV光線の組み合わせも重要; photodermatitis
•

日光に暴露している部位の掻痒感, 皮疹,
二重に衣服をまとっている部位が保たれる場合は疑う.

•

Thiazide, テトラサイクリン, ACEI, CCB, NSAID, キニジン,
アミオダロンは報告例が多い日光過敏を引き起こす薬剤.

•

他にも原因となる薬剤は多く,
日光過敏出現から6wk以内に開始した薬剤は中止すべき.
Clinical Review & Education Care of the Aging Patient: From Evidence to Action

Pruritus in the Older Patient

Table 2. Key History and Physical Examination Elements in the Diagnosis of Pruritic Skin Conditions Common in Elderly Persons
Condition

History

Physical Examination

Xerotic eczema

Improves with bathing, worse when dry; primarily affects lower legs and arms; spares the armpits, groin,
face, and scalp

Can have minimal changes; fissured, slightly scaly, poorly
defined patches

Scabies

Severe pruritus; recent stay in long-term care facility

Small papules and linear lesions of the axillae, groin (vulva
and scrotum), navel, finger-webs

Photodermatitis

Photosensitizing medication; worse after sun exposure
(eg, long car trip)

Confluent patches favoring dorsal hands, brachioradial arms,
“V” upper chest area, posterior neck, and face

Grover disease

Worse after sweating (even in winter)

2- to 4-mm slightly scaly red papules of the inframammary
chest/upper abdomen and central back

Bullous pemphigoid

Severe pruritus

Urticarial plaques or bullae favoring the inner aspects of
proximal arms and thighs and flanks; surrounding erythema
may or may not be present

Drug-induced skin eruption

New medication (eg, calcium channel blocker or
hydrochlorothiazide)

Many morphologies; widespread symmetrical erythema

Cutaneous T-cell lymphoma
(mycosis fungoides type)

Long duration; pruritus minimal to severe

Slightly scaly large patches with atrophy at times with
pigment change; loss of hair in lesions; often begins on lower
back, buttocks, upper thighs (bathing trunk distribution)

Patients with end-stage renal disease who are undergoing hemodialysis commonly have chronic pruritus. Initially, dialysis should
be optimized and the patient treated for xerosis. If this is ineffective, gabapentin, 300 mg, or pregabalin, 75 mg, after each dialysis
session are equally effective in treating the pruritus of end-stage renal disease.33 In refractory renal pruritus, UV-B phototherapy is of-

with diabetes with dysesthesia of the toes and soles, absence of
the Achilles tendon reflex bilaterally, and impaired change in blood
pressure with a head-up tilt test are 1.5 to 2 times more likely to
report truncal pruritus.15
Except for allergic contact dermatitis, dermatological and systemic diseases tend to cause generalized or multifocal itch, so a re-
•

身体所見での注意点;
•

掻痒部位の皮疹の有無の確認は重要.
掻爬痕なのか, 皮疹なのか

•

皮疹があればそれに対して外用を使用するか,
皮膚科コンサルトするか, 皮膚生検を行うか.

•

皮疹の部位が指の皺, 手首, 足の裏, 鼠径, 陰部, 乳房ならば,
疥癬の可能性が高い.

•

皮疹が無い場合, 乾燥皮膚, 神経症, 全身疾患,
悪性腫瘍の可能性が上がる
on

掻痒感への対応
Pruritus in the Older Patient

Table 1. Treatments for Pruritus and Their Costs

•

Pruritus Treatment by Etiology

原因と掻痒感に対する治療

Cost, $a

Xerosis
Moisturizers
White petrolatum, 13 oz
Moisturizing cream (tub-style container), 16 oz

5
10-15

Soothing topical lotions or creams
Anti-itch lotions, 7 oz

8-11

Inflammation
Topical steroids
Triamcinolone ointment, 0.1%, 80 g/1 lb

18/49

Fluocinonide ointment, 0.05%, 60 g

50

Renal pruritus

•

皮膚乾燥症への対応

γ-Aminobutyric acid analog33

Pruritus in the Older Patient

Gabapentin, 300 mg, 90 pills

20

Pregabalin, 75 mg, 30 pills

95

UV-B phototherapy, per treatment34b
Hepatic pruritus

Box 2. Xerosis: Basic Principles of Management
1. Restrict soap to axilla, groin, scalp, and soles.
2. Perform less frequent (less than once per day) bathing with warm,
not hot, bath or shower water.
3. Avoid topical alcohol (astringents) and high-concentration lactic
acid (>5%).
4. Apply petrolatum or petrolatum-containing moisturizer (cream or
ointment, not lotion) immediately after bathing.

50-100

Opiate antagonists35
Naltrexone, 50 mg, 30 pills
Butorphanol nasal spray, 2.5 mL
UV-B phototherapy, per treatment36b

105
57
50-100

Neurogenic pruritus
Topical capsaicin, 1.5 oz

9-15

Capsaicin patches, 3-4 patches

6-12

Topical lidocaine ointment, 5%, 35 g
Lidocaine patch, 5%, 30 patches

38
221

a

All costs are from http://www.drugstore.com, either online or through
Epocrates.

b

Cost estimated based on the Medicare physician fee schedule.37
•

難治性の掻痒感に対しては, 積極的な保湿が有効なことがある
特に皮膚乾燥症と炎症性皮膚炎.

Older Patient

Care of the Aging Patient: From Evidence to Action Clinical Review & Education

Older Patient

Care of the Aging Patient: From Evidence to Action Clinical Review & Education

•

方法は “soak and smear” もしくは “wet wraps”

ments for Pruritus and Their Costs
ments for Pruritus and Their Costs

ment by Etiology

Cost, $a

ment by Etiology

Cost, $a

s

srolatum, 13 oz

5

rolatum, (tub-style container), 16 oz
ing cream13 oz

5
10-15

ing cream (tub-style container), 16 oz
topical lotions or creams

10-15

topical lotions
ch lotions, 7 oz or creams

8-11

ch lotions, 7 oz

8-11

Box 3. Soak-and-Smear Method
Box 3. Soak-and-Smear Method
1. Soak for 10 to 20 minutes in a tub of comfortably warm (not hot)
1. water. 10 to 20 minutes in a tub of comfortably warm (not hot)
Soak for
2. Pat dry.
water.
3. Apply moisturizer to affected skin.
2. Pat dry. 水気をとる
4. Occlude the moisturizer with kitchen plastic wrap or vinyl suit for
3. Apply moisturizer to affected skin.
4. at least 4the moisturizer with kitchen plastic wrap or vinyl suit for
Occlude hours.
5. Frequency is twice daily for severe cases, once daily otherwise.
at least 4 hours.
5. Frequency is twice daily for severe cases, once daily otherwise.

oids

oids
olone ointment, 0.1%, 80 g/1 lb

18/49

olone ointment, 0.1%, 80 g/1
nide ointment, 0.05%, 60 g lb

18/49
50

ide ointment, 0.05%, 60 g

50

yric acid analog33

33
yric acid analogpills
in, 300 mg, 90

20

in, 300 mg, 90 pills
n, 75 mg, 30 pills

20
95

n, 75 mg, 30 pills
therapy, per treatment34b

95
50-100

therapy, per treatment34b
us

50-100

us
gonists35

Box 4. Wet Wraps
Box 4. Wet Wraps
1. Bathe or apply a thin film of water onto affected skin.
2. Pat dry. apply a thin film of water onto affected skin.
1. Bathe or
3. Apply moisturizer.
2. Pat dry.
4. Put onmoisturizer.
3. Apply a moist garment (eg, light sweat suit, soft long under4. wear, pajamas). garment (eg, light sweat suit, soft long underPut on a moist
5. Apply pajamas). garment a similar dry garment.
wear, over moist
6. Frequency is twice daily for severe cases, once daily otherwise.
5. Apply over moist garment a similar dry garment.

6. Frequency is twice daily for severe cases, once daily otherwise.

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Git j club mistakes at ogd.
Git j club mistakes at ogd.Git j club mistakes at ogd.
Git j club mistakes at ogd.
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Febrile neutropenia by DR saqib ahmad shah PG radiation oncology SKIMS KASHMIR
Febrile neutropenia by DR saqib ahmad shah PG radiation oncology SKIMS KASHMIRFebrile neutropenia by DR saqib ahmad shah PG radiation oncology SKIMS KASHMIR
Febrile neutropenia by DR saqib ahmad shah PG radiation oncology SKIMS KASHMIR
 
Febrile neutropenia ankur
Febrile neutropenia ankurFebrile neutropenia ankur
Febrile neutropenia ankur
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Diabetic foot osteomyelitis (1)
Diabetic foot osteomyelitis (1)Diabetic foot osteomyelitis (1)
Diabetic foot osteomyelitis (1)
 
Candiduria
CandiduriaCandiduria
Candiduria
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Febrile neutropenia in chidren
Febrile neutropenia in chidrenFebrile neutropenia in chidren
Febrile neutropenia in chidren
 
Uti and std 2 26-19
Uti and std 2 26-19Uti and std 2 26-19
Uti and std 2 26-19
 
Mendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseasesMendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseases
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Complicated uti
Complicated uti Complicated uti
Complicated uti
 
Chapter 30 febrile neutropenia
Chapter 30 febrile neutropeniaChapter 30 febrile neutropenia
Chapter 30 febrile neutropenia
 
Necrotizing fasciitis
Necrotizing fasciitisNecrotizing fasciitis
Necrotizing fasciitis
 
CASE SENERIO Dr Ayman RefaieMD
 CASE SENERIO  Dr Ayman RefaieMD CASE SENERIO  Dr Ayman RefaieMD
CASE SENERIO Dr Ayman RefaieMD
 
Approach to neutropenia dre bikal
Approach to neutropenia dre bikalApproach to neutropenia dre bikal
Approach to neutropenia dre bikal
 
malakoplakia
malakoplakiamalakoplakia
malakoplakia
 
Febrile neutropenia---paediatrics
Febrile neutropenia---paediatricsFebrile neutropenia---paediatrics
Febrile neutropenia---paediatrics
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
 

Andere mochten auch (20)

Microvascular angina
Microvascular anginaMicrovascular angina
Microvascular angina
 
SLEと妊娠
SLEと妊娠SLEと妊娠
SLEと妊娠
 
インフルエンザの二次感染 ~市中型MRSA感染の合併~
インフルエンザの二次感染 ~市中型MRSA感染の合併~インフルエンザの二次感染 ~市中型MRSA感染の合併~
インフルエンザの二次感染 ~市中型MRSA感染の合併~
 
抗生剤一覧
抗生剤一覧抗生剤一覧
抗生剤一覧
 
好酸球増多
好酸球増多好酸球増多
好酸球増多
 
免疫グロブリン遊離鎖 κ/λ比
免疫グロブリン遊離鎖 κ/λ比免疫グロブリン遊離鎖 κ/λ比
免疫グロブリン遊離鎖 κ/λ比
 
臨床推論2 感度, 特異度
臨床推論2 感度, 特異度臨床推論2 感度, 特異度
臨床推論2 感度, 特異度
 
胸水検査 講義
胸水検査 講義胸水検査 講義
胸水検査 講義
 
心雑音 診察
心雑音 診察心雑音 診察
心雑音 診察
 
多系統萎縮症
多系統萎縮症多系統萎縮症
多系統萎縮症
 
臨床推論
臨床推論臨床推論
臨床推論
 
正常圧水頭症
正常圧水頭症正常圧水頭症
正常圧水頭症
 
輸液、基礎の基礎
輸液、基礎の基礎輸液、基礎の基礎
輸液、基礎の基礎
 
B 5 肺エコー
B 5 肺エコーB 5 肺エコー
B 5 肺エコー
 
Truyện Dragon ball tập 29
Truyện Dragon ball tập 29Truyện Dragon ball tập 29
Truyện Dragon ball tập 29
 
O 爪の所見
O 爪の所見O 爪の所見
O 爪の所見
 
G 1 貧血3 巨赤芽球性
G 1 貧血3 巨赤芽球性G 1 貧血3 巨赤芽球性
G 1 貧血3 巨赤芽球性
 
臨床推論3 アッペの数字
臨床推論3 アッペの数字臨床推論3 アッペの数字
臨床推論3 アッペの数字
 
橋これ
橋これ橋これ
橋これ
 
Gim
GimGim
Gim
 

Ähnlich wie 高齢者の掻痒感

Role of Triamcinolone in Hypertrophic scar and keloid
Role of Triamcinolone in Hypertrophic scar and keloidRole of Triamcinolone in Hypertrophic scar and keloid
Role of Triamcinolone in Hypertrophic scar and keloidDr. Hardik Dodia
 
Benign diseases-of-the-vulvavagina-and - copy
Benign diseases-of-the-vulvavagina-and - copyBenign diseases-of-the-vulvavagina-and - copy
Benign diseases-of-the-vulvavagina-and - copyahmed afify
 
Module 8Amoebiasis_Giardiasis_Pediculosis_Scabies.ppt
Module 8Amoebiasis_Giardiasis_Pediculosis_Scabies.pptModule 8Amoebiasis_Giardiasis_Pediculosis_Scabies.ppt
Module 8Amoebiasis_Giardiasis_Pediculosis_Scabies.pptEdwinOmare
 
Psoriasis lecture south yemen
Psoriasis lecture south yemenPsoriasis lecture south yemen
Psoriasis lecture south yemenMonther AL Gahafi
 
Initial skin lesion
Initial skin lesionInitial skin lesion
Initial skin lesionHabrol Afzam
 
common skin condition in children..pptx
common skin condition in children..pptxcommon skin condition in children..pptx
common skin condition in children..pptxMohanapriyaRajendran6
 
common skin condition in children..pptx
common skin condition in children..pptxcommon skin condition in children..pptx
common skin condition in children..pptxMohanapriyaRajendran6
 
Pruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Pruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. indiaPruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Pruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. indiaalka mukherjee
 
psoriasis-160716060900.pdf
psoriasis-160716060900.pdfpsoriasis-160716060900.pdf
psoriasis-160716060900.pdfShaliniN51
 
Common Skin Diseases
Common Skin DiseasesCommon Skin Diseases
Common Skin Diseasesdoctorshazly
 
Dermatologic condition NB from NKP hospital
Dermatologic condition NB from NKP hospitalDermatologic condition NB from NKP hospital
Dermatologic condition NB from NKP hospitalqjmdfswthk
 
psoriasis complete information including therapy
psoriasis complete information including therapypsoriasis complete information including therapy
psoriasis complete information including therapyPavani555
 
Anthelmintics drugs by dr.Bashar Ibrahim
Anthelmintics drugs by dr.Bashar IbrahimAnthelmintics drugs by dr.Bashar Ibrahim
Anthelmintics drugs by dr.Bashar IbrahimLapZerin
 
Cutaneous malignancies.pptx
Cutaneous malignancies.pptxCutaneous malignancies.pptx
Cutaneous malignancies.pptxMaheshAdhikari19
 

Ähnlich wie 高齢者の掻痒感 (20)

Role of Triamcinolone in Hypertrophic scar and keloid
Role of Triamcinolone in Hypertrophic scar and keloidRole of Triamcinolone in Hypertrophic scar and keloid
Role of Triamcinolone in Hypertrophic scar and keloid
 
Benign diseases-of-the-vulvavagina-and - copy
Benign diseases-of-the-vulvavagina-and - copyBenign diseases-of-the-vulvavagina-and - copy
Benign diseases-of-the-vulvavagina-and - copy
 
Burn
BurnBurn
Burn
 
ECZEMA.pptx
ECZEMA.pptxECZEMA.pptx
ECZEMA.pptx
 
Module 8Amoebiasis_Giardiasis_Pediculosis_Scabies.ppt
Module 8Amoebiasis_Giardiasis_Pediculosis_Scabies.pptModule 8Amoebiasis_Giardiasis_Pediculosis_Scabies.ppt
Module 8Amoebiasis_Giardiasis_Pediculosis_Scabies.ppt
 
Psoriasis lecture south yemen
Psoriasis lecture south yemenPsoriasis lecture south yemen
Psoriasis lecture south yemen
 
Initial skin lesion
Initial skin lesionInitial skin lesion
Initial skin lesion
 
BURNS SURGER ..Dr.Abbas
BURNS SURGER ..Dr.AbbasBURNS SURGER ..Dr.Abbas
BURNS SURGER ..Dr.Abbas
 
psoriasis kk 31.ppt
psoriasis kk 31.pptpsoriasis kk 31.ppt
psoriasis kk 31.ppt
 
Dermatology
DermatologyDermatology
Dermatology
 
common skin condition in children..pptx
common skin condition in children..pptxcommon skin condition in children..pptx
common skin condition in children..pptx
 
common skin condition in children..pptx
common skin condition in children..pptxcommon skin condition in children..pptx
common skin condition in children..pptx
 
Pruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Pruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. indiaPruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Pruritis in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
 
psoriasis-160716060900.pdf
psoriasis-160716060900.pdfpsoriasis-160716060900.pdf
psoriasis-160716060900.pdf
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Common Skin Diseases
Common Skin DiseasesCommon Skin Diseases
Common Skin Diseases
 
Dermatologic condition NB from NKP hospital
Dermatologic condition NB from NKP hospitalDermatologic condition NB from NKP hospital
Dermatologic condition NB from NKP hospital
 
psoriasis complete information including therapy
psoriasis complete information including therapypsoriasis complete information including therapy
psoriasis complete information including therapy
 
Anthelmintics drugs by dr.Bashar Ibrahim
Anthelmintics drugs by dr.Bashar IbrahimAnthelmintics drugs by dr.Bashar Ibrahim
Anthelmintics drugs by dr.Bashar Ibrahim
 
Cutaneous malignancies.pptx
Cutaneous malignancies.pptxCutaneous malignancies.pptx
Cutaneous malignancies.pptx
 

Mehr von Katsushige Takagishi (20)

Cryoglobulinemia
CryoglobulinemiaCryoglobulinemia
Cryoglobulinemia
 
結膜炎 JAMA 2013
結膜炎 JAMA 2013結膜炎 JAMA 2013
結膜炎 JAMA 2013
 
Fulminant type 1 dm
Fulminant type 1 dmFulminant type 1 dm
Fulminant type 1 dm
 
強皮症腎クリーゼ
強皮症腎クリーゼ強皮症腎クリーゼ
強皮症腎クリーゼ
 
Crps
CrpsCrps
Crps
 
Whipple病
Whipple病Whipple病
Whipple病
 
伝染性単核症
伝染性単核症伝染性単核症
伝染性単核症
 
真性多血症 本態性血小板増多症
真性多血症 本態性血小板増多症真性多血症 本態性血小板増多症
真性多血症 本態性血小板増多症
 
熱中症
熱中症熱中症
熱中症
 
PSP
PSPPSP
PSP
 
好中球減少性発熱
好中球減少性発熱好中球減少性発熱
好中球減少性発熱
 
血小板 Itp
血小板 Itp血小板 Itp
血小板 Itp
 
Pneumocystis carinii
Pneumocystis cariniiPneumocystis carinii
Pneumocystis carinii
 
Migraine aura without headache
Migraine aura without headacheMigraine aura without headache
Migraine aura without headache
 
気管軟化症 EDAC
気管軟化症 EDAC気管軟化症 EDAC
気管軟化症 EDAC
 
横断性脊髄炎 多発性硬化症について
横断性脊髄炎 多発性硬化症について横断性脊髄炎 多発性硬化症について
横断性脊髄炎 多発性硬化症について
 
脂肪塞栓
脂肪塞栓脂肪塞栓
脂肪塞栓
 
卵円孔開存
卵円孔開存卵円孔開存
卵円孔開存
 
間質性膀胱炎
間質性膀胱炎間質性膀胱炎
間質性膀胱炎
 
DLB Dementia with Lewy bodies
DLB Dementia with Lewy bodiesDLB Dementia with Lewy bodies
DLB Dementia with Lewy bodies
 

Kürzlich hochgeladen

CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.pptraviapr7
 

Kürzlich hochgeladen (20)

CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.ppt
 

高齢者の掻痒感

  • 3. • 皮膚バリア機能の低下 • 皮膚の保水性は皮膚表面の脂質複合体が関与している. Care of the Aging Patient: From Evidence to Action Clinical Review & Education Pruritus in the Older Patient この複合体層は非常に薄く, テープを10-20回剥がすと全て無くなる位 Figure. The Epidermal Water Barrier Epidermal water barrier 高齢者ではこの層の修復速度, Lipid lamellae S T R AT U M C O R N E U M ( S C ) 機能自体が低下. 3 Lipid processing Corneocytes SG-SC interface Corneocyte 感想皮膚は≥65yの50%以上で Lamellar body contents 認められる所見. S T R AT U M G R A N U L O S U M ( S G ) Granular cells 2 Lipid secretion Lamellar body (containing lipids and enzymes) S T R AT U M S P I N O S U M Spinous cells 1 Lipid synthesis Granular cell S T R AT U M B A S A L E Basal cells Spinous cell DERMIS The keratinocytes of the granular cell layer make and secrete lipid into the spaces between corneocytes, the anucleate keratinocytes of the stratum corneum. This lipid is processed by enzymes into lipid bilayers that are an effective water barrier. Individuals of advanced age (>80 years) have reduced lipid synthesis and secretion. Moderately aged individuals (50-80 years) make and secrete lipid normally but have a defect in lipid processing. Patients of advanced age and, to a lesser extent, moderate age both form a less effective water barrier and repair a damaged barrier (caused by irritants such as detergents and soaps) less effectively.
  • 5. 掻痒感への対応 Clinical Review & Education Care of the Aging Patient: From Evidence to Actio • 先ずチェックするポイント Box 1. Evaluation and Management of Elderly Patients With Pruritus • 掻痒についての病歴, 部位 • 薬剤の評価(外用, 内服) • 疥癬, 皮膚乾燥のチェック • Lab; 肝不全, 腎不全, 電解質  甲状腺機能異常のチェック. 1. Take directed history detailing severity (on a 0-10 scale), location (localized vs generalized), and modifying factors for the patient’s itch (bathing). 2. Review medications (topical and systemic). 3. Perform physical examination for evidence of scabies (burrows, genital lesions) and dry skin (fissured, red patches on legs, flanks, and arms). 4. Order basic laboratory evaluation (complete blood cell count, fasting plasma glucose, thyrotropin, liver function tests, serum urea nitrogen/creatinine, calcium, phosphorus). 5. Treat for xerosis. 6. Treat for scabies if found. 7. If rash is present, initiate topical therapy, obtain potassium hydroxide preparation, order skin biopsy, or refer to a dermatologist if initial therapy does not improve the rash. 8. If no rash is present, initiate metabolic workup (thyroid, parathyroid, iron deficiency) and evaluate for malignancy or for neuropathy. If no rash is present and skin changes are due to scratching, assess for scabies, obtain a potassium hydroxide preparation, consider skin biopsy, pursue a metabolic workup, and evaluate for malignancy or neuropathy.
  • 6. • • 乾燥皮膚, 疥癬があれば対応 皮疹があれば, *水酸化カリウム外用; カリ石ケン® Clinical Review & Education Care of the Aging Patient: From Evidence to Actio • まず水酸化カリウム外用を使用 改善なければ皮膚生検 or皮膚科へ. • 皮疹がなければ, • 代謝内分泌のチェック (甲状腺, 副甲状腺, 鉄欠乏) 悪性腫瘍, 神経症のチェック • 水酸化K外用を使用し, 改善なければ生検 or 皮膚科へ Box 1. Evaluation and Management of Elderly Patients With Pruritus 1. Take directed history detailing severity (on a 0-10 scale), location (localized vs generalized), and modifying factors for the patient’s itch (bathing). 2. Review medications (topical and systemic). 3. Perform physical examination for evidence of scabies (burrows, genital lesions) and dry skin (fissured, red patches on legs, flanks, and arms). 4. Order basic laboratory evaluation (complete blood cell count, fasting plasma glucose, thyrotropin, liver function tests, serum urea nitrogen/creatinine, calcium, phosphorus). 5. Treat for xerosis. 6. Treat for scabies if found. 7. If rash is present, initiate topical therapy, obtain potassium hydroxide preparation, order skin biopsy, or refer to a dermatologist if initial therapy does not improve the rash. 8. If no rash is present, initiate metabolic workup (thyroid, parathyroid, iron deficiency) and evaluate for malignancy or for neuropathy. If no rash is present and skin changes are due to scratching, assess for scabies, obtain a potassium hydroxide preparation, consider skin biopsy, pursue a metabolic workup, and evaluate for malignancy or neuropathy.
  • 7. • 病歴での注意点; • 掻痒感の程度はVASを使用する. 6-8pt以上ならば睡眠を障害するくらいの掻痒感と捉え, 積極的に介入. • 強い掻痒感では疥癬を必ずチェック. 特に突如発症で施設入所歴が ある場合, 頭皮がスペアされる場合はさらに疑う • 入浴との関連も重要な情報. 入浴にて軽快する場合は乾燥皮膚を示唆する病歴. 入浴後分∼時間単位で再出現し, 入浴で改善すればさらに有用. • 乾燥皮膚では湿度の低い冬場で特に増悪し, 四肢, 体幹の掻痒感が多く, 湿っている腋窩, 鼠径, 顔面, 頭皮では 少ないこともポイント.
  • 10. • 薬剤とUV光線の組み合わせも重要; photodermatitis • 日光に暴露している部位の掻痒感, 皮疹, 二重に衣服をまとっている部位が保たれる場合は疑う. • Thiazide, テトラサイクリン, ACEI, CCB, NSAID, キニジン, アミオダロンは報告例が多い日光過敏を引き起こす薬剤. • 他にも原因となる薬剤は多く, 日光過敏出現から6wk以内に開始した薬剤は中止すべき.
  • 11. Clinical Review & Education Care of the Aging Patient: From Evidence to Action Pruritus in the Older Patient Table 2. Key History and Physical Examination Elements in the Diagnosis of Pruritic Skin Conditions Common in Elderly Persons Condition History Physical Examination Xerotic eczema Improves with bathing, worse when dry; primarily affects lower legs and arms; spares the armpits, groin, face, and scalp Can have minimal changes; fissured, slightly scaly, poorly defined patches Scabies Severe pruritus; recent stay in long-term care facility Small papules and linear lesions of the axillae, groin (vulva and scrotum), navel, finger-webs Photodermatitis Photosensitizing medication; worse after sun exposure (eg, long car trip) Confluent patches favoring dorsal hands, brachioradial arms, “V” upper chest area, posterior neck, and face Grover disease Worse after sweating (even in winter) 2- to 4-mm slightly scaly red papules of the inframammary chest/upper abdomen and central back Bullous pemphigoid Severe pruritus Urticarial plaques or bullae favoring the inner aspects of proximal arms and thighs and flanks; surrounding erythema may or may not be present Drug-induced skin eruption New medication (eg, calcium channel blocker or hydrochlorothiazide) Many morphologies; widespread symmetrical erythema Cutaneous T-cell lymphoma (mycosis fungoides type) Long duration; pruritus minimal to severe Slightly scaly large patches with atrophy at times with pigment change; loss of hair in lesions; often begins on lower back, buttocks, upper thighs (bathing trunk distribution) Patients with end-stage renal disease who are undergoing hemodialysis commonly have chronic pruritus. Initially, dialysis should be optimized and the patient treated for xerosis. If this is ineffective, gabapentin, 300 mg, or pregabalin, 75 mg, after each dialysis session are equally effective in treating the pruritus of end-stage renal disease.33 In refractory renal pruritus, UV-B phototherapy is of- with diabetes with dysesthesia of the toes and soles, absence of the Achilles tendon reflex bilaterally, and impaired change in blood pressure with a head-up tilt test are 1.5 to 2 times more likely to report truncal pruritus.15 Except for allergic contact dermatitis, dermatological and systemic diseases tend to cause generalized or multifocal itch, so a re-
  • 13. on 掻痒感への対応 Pruritus in the Older Patient Table 1. Treatments for Pruritus and Their Costs • Pruritus Treatment by Etiology 原因と掻痒感に対する治療 Cost, $a Xerosis Moisturizers White petrolatum, 13 oz Moisturizing cream (tub-style container), 16 oz 5 10-15 Soothing topical lotions or creams Anti-itch lotions, 7 oz 8-11 Inflammation Topical steroids Triamcinolone ointment, 0.1%, 80 g/1 lb 18/49 Fluocinonide ointment, 0.05%, 60 g 50 Renal pruritus • 皮膚乾燥症への対応 γ-Aminobutyric acid analog33 Pruritus in the Older Patient Gabapentin, 300 mg, 90 pills 20 Pregabalin, 75 mg, 30 pills 95 UV-B phototherapy, per treatment34b Hepatic pruritus Box 2. Xerosis: Basic Principles of Management 1. Restrict soap to axilla, groin, scalp, and soles. 2. Perform less frequent (less than once per day) bathing with warm, not hot, bath or shower water. 3. Avoid topical alcohol (astringents) and high-concentration lactic acid (>5%). 4. Apply petrolatum or petrolatum-containing moisturizer (cream or ointment, not lotion) immediately after bathing. 50-100 Opiate antagonists35 Naltrexone, 50 mg, 30 pills Butorphanol nasal spray, 2.5 mL UV-B phototherapy, per treatment36b 105 57 50-100 Neurogenic pruritus Topical capsaicin, 1.5 oz 9-15 Capsaicin patches, 3-4 patches 6-12 Topical lidocaine ointment, 5%, 35 g Lidocaine patch, 5%, 30 patches 38 221 a All costs are from http://www.drugstore.com, either online or through Epocrates. b Cost estimated based on the Medicare physician fee schedule.37
  • 14. • 難治性の掻痒感に対しては, 積極的な保湿が有効なことがある 特に皮膚乾燥症と炎症性皮膚炎. Older Patient Care of the Aging Patient: From Evidence to Action Clinical Review & Education Older Patient Care of the Aging Patient: From Evidence to Action Clinical Review & Education • 方法は “soak and smear” もしくは “wet wraps” ments for Pruritus and Their Costs ments for Pruritus and Their Costs ment by Etiology Cost, $a ment by Etiology Cost, $a s srolatum, 13 oz 5 rolatum, (tub-style container), 16 oz ing cream13 oz 5 10-15 ing cream (tub-style container), 16 oz topical lotions or creams 10-15 topical lotions ch lotions, 7 oz or creams 8-11 ch lotions, 7 oz 8-11 Box 3. Soak-and-Smear Method Box 3. Soak-and-Smear Method 1. Soak for 10 to 20 minutes in a tub of comfortably warm (not hot) 1. water. 10 to 20 minutes in a tub of comfortably warm (not hot) Soak for 2. Pat dry. water. 3. Apply moisturizer to affected skin. 2. Pat dry. 水気をとる 4. Occlude the moisturizer with kitchen plastic wrap or vinyl suit for 3. Apply moisturizer to affected skin. 4. at least 4the moisturizer with kitchen plastic wrap or vinyl suit for Occlude hours. 5. Frequency is twice daily for severe cases, once daily otherwise. at least 4 hours. 5. Frequency is twice daily for severe cases, once daily otherwise. oids oids olone ointment, 0.1%, 80 g/1 lb 18/49 olone ointment, 0.1%, 80 g/1 nide ointment, 0.05%, 60 g lb 18/49 50 ide ointment, 0.05%, 60 g 50 yric acid analog33 33 yric acid analogpills in, 300 mg, 90 20 in, 300 mg, 90 pills n, 75 mg, 30 pills 20 95 n, 75 mg, 30 pills therapy, per treatment34b 95 50-100 therapy, per treatment34b us 50-100 us gonists35 Box 4. Wet Wraps Box 4. Wet Wraps 1. Bathe or apply a thin film of water onto affected skin. 2. Pat dry. apply a thin film of water onto affected skin. 1. Bathe or 3. Apply moisturizer. 2. Pat dry. 4. Put onmoisturizer. 3. Apply a moist garment (eg, light sweat suit, soft long under4. wear, pajamas). garment (eg, light sweat suit, soft long underPut on a moist 5. Apply pajamas). garment a similar dry garment. wear, over moist 6. Frequency is twice daily for severe cases, once daily otherwise. 5. Apply over moist garment a similar dry garment. 6. Frequency is twice daily for severe cases, once daily otherwise.